Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

Clinical trial NCT06939088 · RECRUITING

Trial details

NCT number: NCT06939088
Sponsor: Anders Fink-Jensen, MD, DMSci
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Use Disorder Alcohol Abuse/Dependence Alcohol Dependence Alcoholism Schizophrenia Disorders Schizophrenia and Disorders With Psychotic Features Schizophrenia and Schizophrenia Spectrum Psychosis Schizophrenia

Start date: 2025-05-05
Primary completion: 2028-08-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.